6Cipollone F, Fazia M, lezzi A, et al. Suppression of the functionally coupled cyelooxygenase-2/prostaglandin esynthase as a basis of simvastafin-dependent plaque stabilization in humans. Circulation, 2003,107( 11 ) : 1479-1485.
7Girman CJ,Rhodes T,Mercuri M,et al. The metabohc syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atheroscle- rosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol, 2004,93(2) : 136-141.
8Hodel C. Myopalhy and rhabodomyolysis with lipid lowering drugs. Toxieol Lett,2002,128( 1-3 ) : 159-168.
9Hodel Christian. Myopathy and rhabdomyolysis with lipidlowering drugs.Toxicol - Lett,2002,128( 1 - 3) : 159 - 168.
